Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting.

Vachhani, Pankit; Ma, Esprit; Xu, Tao; Montez, Melissa; Worth, Sarah; Yellow-Duke, Archibong; Cheng, Wei-Han; Werner, Michael E; Abbas, Jonathan; Donnellan, William

Vachhani, Pankit; Ma, Esprit; Xu, Tao; Montez, Melissa; Worth, Sarah; Yellow-Duke, Archibong; Cheng, Wei-Han; Werner, Michael E; Abbas, Jonathan; Donnellan, William.

Afiliação

Vachhani P; O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ma E; Genentech, Inc., South San Francisco, California, USA.
Xu T; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Montez M; Genentech, Inc., South San Francisco, California, USA.
Worth S; O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yellow-Duke A; Genentech, Inc., South San Francisco, California, USA.
Cheng WH; AbbVie, Inc., North Chicago, Illinois, USA.
Werner ME; AbbVie, Inc., North Chicago, Illinois, USA.
Abbas J; Tennessee Oncology, Nashville, Tennessee, USA.
Donnellan W; Tennessee Oncology, Nashville, Tennessee, USA.

Cancer Med ; 12(17): 17914-17923, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37568276

Palavras-chave

acute myeloid leukemia; bone marrow assessment; hypomethylating agents; real-world; schedule modifications; survival outcomes; treatment management; venetoclax

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google